FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Launay, J.-M.
Right arrow Articles by Kellermann, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Launay, J.-M.
Right arrow Articles by Kellermann, O.
(The FASEB Journal. 2006;20:1843-1854.)
© 2006 FASEB

Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells

Jean-Marie Launay*,1, Benoit Schneider{dagger}, Sylvain Loric{dagger}, Mose Da Prada{ddagger},2 and Odile Kellermann{dagger}

* Service de Biochimie, IFR 139, Hôpital Lariboisière and Laboratoire de Biologie Cellulaire, EA3621, Faculté de Pharmacie, Université Paris V, Paris, France;

{dagger} Différenciation Cellulaire et Prions, CNRS UPR 1983, Institut André Lwoff, Villejuif, and Institut Pasteur, Département de Biologie Cellulaire et Infections, Paris, France; and

{ddagger} Pharma Research Department, Hoffmann-La Roche A.G., Basel, Switzerland

1Correspondence: Service de Biochimie, Hôpital Lariboisière, 75475 Paris Cedex 10, France. E-mail: jean-marie.launay{at}lrb.aphp.fr

The plasma membrane 5-HT transporter (SERT) is the major protagonist in regulating extracellular 5-HT concentration and constitutes the target of drugs used to treat a host of metabolic and psychiatric disorders. The exact mechanisms sustaining SERT function still remain elusive. The present work exploits the properties of the 1C11 neuroectodermal progenitor, which acquires, upon 4 days of differentiation, a functional SERT within an integrated serotonergic phenotype to investigate regulatory mechanisms involved in SERT onset and functions. We show that poly(A) addition precedes SERT mRNA translation on day 2 of the serotonergic program. The newly translated transporter molecules immediately bind cocaine. Day 4 must be awaited to monitor antidepressant recognition and 5-HT uptake. Because external 5-HT reduces both 5-HT transport and SERT antidepressant binding, we identify 5-HT2B receptors as key players in controlling the overall 5-HT transport system. In the absence of external 5-HT, 5-HT2B receptor coupling to NO production ensures SERT phosphorylation to basal level and maximal 5-HT uptake. In the presence of 5-HT, the 5-HT2B receptor-PKC coupling promotes additional phosphorylations of both SERT and Na+,K+-ATPase {alpha}-subunit, impairing the electrochemical gradient necessary to 5-HT uptake. SERT hyperphosphorylation also affects antidepressant recognition. Finally, such 5-HT2B receptor-mediated control of SERT activity operates in primary neurons from raphe nuclei. Altogether, our data shed new light on the 5-HT-driven post-translational modifications involved in the control of SERT activity.—Launay, J-M., Schneider, B., Loric, S., Da Prada, M., Kellermann, O. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.


Key Words: SERT • neuronal differentiation • transporter(s)




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Doly, E. Valjent, V. Setola, J. Callebert, D. Herve, J.-M. Launay, and L. Maroteaux
Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro
J. Neurosci., March 12, 2008; 28(11): 2933 - 2940.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Collet, C. Schiltz, V. Geoffroy, L. Maroteaux, J.-M. Launay, and M.-C. de Vernejoul
The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation
FASEB J, February 1, 2008; 22(2): 418 - 427.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Janoshazi, M. Deraet, J. Callebert, V. Setola, S. Guenther, B. Saubamea, P. Manivet, J.-M. Launay, and L. Maroteaux
Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors
Mol. Pharmacol., June 1, 2007; 71(6): 1463 - 1474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.